Cyclooxygenase-2 expression: Does it have a probable role in tumorigenesis mechanisms of renal cell carcinoma?

International Urology and Nephrology

Volumn 40, Issue 2, 2008, Pages 295-301

  Sozen, Sinan ^a   Gurocak, Serhat ^a   Erdem, Ozlem ^a   Acar, Cenk ^a   Kordan, Yakup ^a   Akyol, Gulen ^a   Alkibay, Turgut ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Cyclooxygenase 2; Immunohistochemistry; Prognosis; Renal cell carcinoma; Tumorigenesis

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; APOPTOSIS; ARTICLE; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, RENAL CELL; CYCLOOXYGENASE 2; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 52649110581     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-007-9268-9     Document Type: Article

References (28)

1. Landis SH, Murray T, Bolden S et al (1998) Cancer statistics. CA Cancer J Clin 48:6-29
2. Chow WH, Devesa SS, Warren JL et al (1999) Rising incidence of renal cell cancer in United States. JAMA 281:1628-1631
3. Homma Y, Kawabe K, Kitamura T et al (1995) Increased incidental detection and reduced mortality in renal cancerrecent retrospective analysis at eight institutions. Int J Urol 2:77-80
4. Delahunt B (1998) Histopathologic prognostic indicators for renal cell carcinoma. Semin Diagn Pathol 15:68-76
5. Yasunaga Y, Shin M, Miki T et al (1998) Prognostic factors for renal cell carcinoma: a multivariate analysis. J Surg Oncol 68:11-18
6. Giardiello FM, Hamilton SR, Krush AJ et al (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313- 1316
7. Giardiello FM, Offerahus GJA, DuBois RN (1995) The role of nonsteroidal anti inflammatory drugs in colorectal cancer prevention. Eur J Cancer 31:1071-1076
8. Reddy BS, Rao CV, Seibert K (1996) Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 56:4566- 4569
9. Dubois RN, Abramson SB, Crofford L et al (1998) Cyclooxygenase in biology and disease. FASEB J 12:1063-1073
10. De Witt D, Smith WL (1995) Yes, but do they still get headaches? Cell 83:345-348
11. Shi H, Xu JM, Hu N et al (2003) Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma. World J Gastroenterol 9:1421-1426
12. Heuze-Vourc'h N, Zhu L, Krysan K et al (2003) Abnormal interleukin 10Ra expression contributes to the maintenance of elevated cyclooxygenase in non-small cell lung cancer cells. Cancer Res 63:766-770
13. Khan KN, Stanfield KM, Trajkovic D et al (2002) Expression of cyclooxygenase-2 in canine cell carcinoma. Urology 59:615-620
14. Chen Q, Shinohara N, Abe T et al (2004) Significance of Cox-2 expression in human renal cell carcinoma cell lines. Int J Cancer 108:825-832
15. Cho DS, Joo JH, Oh DK et al (2005) Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma. Yonsei Med J 46(1):133-140
16. Miyata Y, Koga S, Kanda S et al (2003) Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2 and survival. Clin Can Res 9:1741-1749
17. Guinan P, Sohin LH, Algaba F et al (1997) TNM staging of renal cell carcinoma: workshop No. 3 Union Internationale Contre Le Cancer [UICC] and the American Joint Committee for Cancer [AJCC]. Cancer 80:992-993
18. Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655-663
19. Hashimoto Y, Kondo Y, Kimura G et al (2004). Cyclooxygenase- 2 expression and relationship to tumor progression in human renal cell carcinoma. Histopathology 44:353-359
20. Hemmerlein B, Galuschka L, Putzer N et al (2004) Comparative analysis of Cox-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas. Histopathology 45:603-611
21. Masunaga R, Kohno H, Dhar DK et al (2000) Cyclooxygenase- 2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res 6:4064-4068
22. Denkert C, Winzer KJ, Müller BM et al (2003) Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma. Cancer 97:2987-2987
23. Chen YJ, Wang LS, Wang PH et al (2003) High cyclooxygenase- 2 expression in cervical adenocarcinomas. Gynecol Oncol 88:379-385
24. Okamoto T, Hara A, Hino O (2003) Down-regulation of cyclooxygenase-2 expression but up-regulation of cyclooxygenase- 1 in renal cell carcinoma of Eker [TSC2 gene mutant] rat model. Cancer Sci 94:22-25
25. Tuna B, Yorukoglu K, Gurel D et al (2004) Significance of Cox-2 expression in human renal cell carcinoma. Urology 64:1116-1120
26. Tsui KH, Shvarts O, Smith RB et al (2000) Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM stating criteria. J Urol 163:1090-1095
27. Mikami T, Yanagisawa N, Baba H et al (1999) Association of Bcl-2 protein expression with gallbladder carcinoma differentiation and prognosis and its relation to apoptosis. Cancer 85:318-325
28. Gohji K, Nomi M, Hara I et al (1998) Influence of cytokines and growth factors on metalloproteinase-2 production and invasion of human cell cancer. Urol Res 26:33-37